
1. j trop med hyg. 2012 sep;87(3):460-9. doi: 10.4269/ajtmh.2012.12-0222. epub
2012 jul 23.

plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally
acquired humoral responses.

molina dm(1), finney oc, arevalo-herrera m, herrera s, felgner pl, gardner mj,
liang x, wang r.

author information: 
(1)antigen discovery inc., irvine, california, usa.

the development pre-erythrocytic plasmodium vivax vaccines hindered 
lack vitro culture systems experimental rodent models. help bypass
these roadblocks, exploited fact naturally exposed fy- individuals
who lack duffy blood antigen (fy) receptor less likely develop
blood-stage infections; therefore, preferentially develop immune responses
to pre-erythrocytic-stage parasites, whereas fy+ individuals experience both
liver- blood-stage infections develop immune responses both
pre-erythrocytic erythrocytic parasites. screened 60 endemic sera p. 
vivax-exposed fy+ fy- donors protein microarray containing 91 p.
vivax proteins p. falciparum orthologs up-regulated in
sporozoites. antibodies 10 p. vivax antigens identified sera from
p. vivax-exposed individuals unexposed controls. technology has
promising implications discovery potential vaccine candidates against
p. vivax malaria.

doi: 10.4269/ajtmh.2012.12-0222 
pmcid: pmc3435348
pmid: 22826492  [indexed medline]

